Psyence Biomedical Ltd. (PBM)
5.00
-0.16
(-3.10%)
USD |
NASDAQ |
Oct 05, 16:00
4.98
-0.02
(-0.40%)
After-Hours: 20:00
Psyence Biomedical Net Income (Quarterly) : -0.7533M for Sept. 30, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -0.7533M |
| September 30, 2024 | 0.1415M |
| September 30, 2023 | -0.6478M |
| June 30, 2023 | -0.0628M |
| March 31, 2023 | -0.0245M |
| December 31, 2022 | 2.250M |
| September 30, 2022 | 0.7668M |
| Date | Value |
|---|---|
| June 30, 2022 | 2.044M |
| March 31, 2022 | 2.953M |
| December 31, 2021 | 8.310M |
| September 30, 2021 | -0.0451M |
| June 30, 2021 | -0.0276M |
| March 31, 2021 | -0.0068M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | -110.74M |
| Aurinia Pharmaceuticals, Inc. | 37.41M |
| enGene Therapeutics, Inc. | -32.50M |
| Medicus Pharma Ltd. | -8.440M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.7533M |
| EPS Diluted (Quarterly) | -3.178 |